Welcome!
Defined Health is a leading business development strategy consulting firm. We’ve been assisting clients in the pharmaceutical, biotech and healthcare investment industries for more than 25 years.

Defined Health has three core lines of business, each focused on helping companies build and strengthen development-stage assets; compounds, portfolios and platforms
A key differentiator is the firm’s focus on defining value for early stage compounds as “proof of relevance” (“PoR”), looking beyond mechanistic proof-of-concept to demonstrate clear potential for clinical differentiation and indisputable commercial value.

Defined Health’s position of trust can be leveraged for the long term, across the continuum of clinical development and “go to” market services.

To learn more click on any of the buttons below.
Capabilities Presentation Search & Evaluation Capabilities

Defined Health Will be Participating in the Following Events:

BioPharm America
Sep 13 - Sep 15, 2016 | Boston, MA
https://ebdgroup.knect365.com/biopharm-america/

Pharma CI USA Conference
Sep 13 - Sep 14, 2016 | Parsippany, NJ
http://dfndhlth.com/PharmaCIUSA

GTC Bio CNS Partnering Conference
Sep 14 - Sep 15, 2016 | Boston, MA
https://www.gtcbio.com/conferences/cns-partnering-deal-making-overview?utm_source=conferenceposting

More...

About Us

Defined Health is a leading business development strategy consulting firm. We’ve been assisting clients in the pharmaceutical, biotech and healthcare investment industries for more than 25 years.

  • Defined Health has three core lines of business, each focused on helping companies build and strengthen development-stage assets; compounds, portfolios and platforms
  • A key differentiator is the firm’s focus on defining value for early stage compounds as “proof of relevance” (“PoR”), looking beyond mechanistic proof-of-concept to demonstrate clear potential for clinical differentiation and indisputable commercial value
  • Defined Health’s position of trust can be leveraged for the long term, across the continuum of clinical development and “go to” market services

button-op-assest button-op-porf-platform button-id-eval-opport

  • Validate scientific rationale
  • Position in evolving standard of care
  • Define target patient populations, clinical endpoints and target product profiles
  • Determine payer perspective
  • Assess commercial value

  • Analyze and prioritize pipeline portfolio
  • Identify and assess novel indications for development
  • Prioritize potential indications
  • Define value inflection strategy for clinical candidates
  • Advise on optimal time and stage of development for partnering
  • Advise on partner selection

  • Establish criteria for identifying programs that fit with strategy
  • Identify assets and/or companies that best match criteria
  • Provide deeper analysis of priority targets
  • Identify value inflection points to optimize partnering strategy
  • Leverage extensive industry network to identify potential strategic partners

 

Fact Sheet  Experience

 

Principals

Defined Health is pleased to be presenting

Defined Health will be participating in the following events

Testimonials

“We love working with the Defined Health team. By seeing the whole field, they make connections that others can’t. We count on their rigorous scientific and business analysis to provide insights that can be applied across the board — from industry trends to individual projects.”

PTCTherapeutics
Stuart W. Peltz, PhD, Chief Executive Officer PTC Therapeutics, Inc.

“Defined Health is rapidly becoming our “go to” adviser for topics reaching from market analysis of therapeutics to more wide-ranging strategic questions. The quality of their work, the thoughtfulness of their approach and their speed make them a pleasure to work with.”

Morphosys
Simon Moroney, D.Phil., Chief Executive Officer MorphoSys AG

“We’ve used Defined Health for a number of projects to help us analyze the potential of new applications for our technology. The results of the research and the reports that were generated were key tools in our strategic planning and decision making process, both at the Senior Management level, and with our Board of Directors. Our projects with Defined Health have been key to shaping the present and future of Tekmira.”

Tekmira
Paul Brennan, Senior Vice President, Business Development Tekmira Pharmaceuticals Corporation

“The Defined Health team that conducted our market and payer research project in five countries worked with us seamlessly from project inception through final presentation (and beyond!). I cannot say enough about the pride of ownership Ed and Vasantha took, making sure every step of the project was done with the highest level of professionalism. Upon sharing the findings of the project with potential pharmaceutical partners, we heard consistent feedback that the Defined Health name is highly respected and the work product was completely credible. One top-tier pharmaceutical company was impressed that our project was done to the level and quality that they would perform. Our lead asset could not have come to life and revealed its market value any better than it did as a result of your outstanding work. I firmly believe Defined Health provides exceptional market insights and value for your fee”

logo
Mark C. Wiggins, Senior Vice President, Corporate & Business Development Elcelyx Therapeutics

“Defined Health has been a valuable strategic partner to Teva for many years. We value their extensive pharma market knowledge and strategic insight!”

Teva
Jill M. Forrest, (Former) Vice President, Oncology Global Strategic Marketing Teva Pharmaceuticals

“We turn to Defined Health for the quality of their analytical work and their insight on the markets and development pathways for biotechnology products. They have done excellent work for us on a number of different projects, and their input has helped advance our own thinking about our programs. Jeff Bockman and the rest of the team have been great to work with.”

GlycoMimetics
Rachel K. King, Chief Executive Officer GlycoMimetics, Inc.

“Thank you for providing the final report which is a perfect summary of the great work that you have done. It was likewise a pleasure working with you. We really enjoyed your deep knowledge of the field, the great discussions we had and the on-time delivery of all work packages. We have strongly benefited from your research on ATIR and the factors involved in determining its future success. It would be a pleasure working with you again on another project.”

kiadis
Manfred Ruediger, PhD, Chief Executive Officer Kiadis Pharma

“As a busy clinician cardiologist I am always thinking about creative applications of cutting edge science. Defined Health is exactly that and more. Working on a project with DH recently was so much fun I feel like I should be paying them! Every single time I have an interaction with DH I feel the same way – blown away and intellectually excited all at once. They are way more than a market research company. Defined Health is on my very short list of people and companies with whom I really like working.

Nate E. Lebowitz, MD, FACC, Advanced Cardiology Institute Division, Hackensack University Medical Center, Cardiovascular Partners Hackensack University Medical Center

“Thank you for putting on your therapeutic area webinars. They’re great! What I like most about them is that I can catch up on the state-of-the-art commercial thinking and apply it to early development efforts.”

Thomas A. Collet, PhD, President, CEO, and Co-founder Phrixus Pharmaceuticals

“We are extremely pleased with the exceptional quality of the product develoment and commercialization strategy work that Defined Health conducted for Lineagen. Defined Health’s research was rigorous, credible and relevant, and was vital in helping Lineagen develop a clear path and forward-looking strategy. In fact, Defined Health’s research directly led to Lineagen’s first commercialized service, which is now a revenue-generating business for Lineagen.”

Lineagen
Michael S. Paul, PhD, President and CEO Lineagen, Inc

“We approached Defined Health with a unique challenge: Help a charity, The Leukemia & Lymphoma Society (LLS), understand in great detail the treatment and research landscape of the hematological malignancies and use this information to define unmet needs against which LLS could deploy resources (its $100 MM annual mission budget) to accelerate the development of new therapies. The work product created by the professional staff at DH greatly exceeded our expectations. The implementation of DH recommendations has resulted in an exciting new research funding philosophy and strategic research direction for LLS.”

lls
Louis J. DeGennaro, PhD, Executive Vice President, Chief Mission Officer The Leukemia & Lymphoma Society

“I have used Defined Health on many occasions over the past 10+ years on projects that required significant strategic as well as market assessment decision making skills. They have delivered on every project and have met deadlines which were very tight. What I appreciate most about the DH team is the sense of ‘getting it done right’. They will not consider a job done unless it is done to the satisfaction of the client. Another key attribute I have come to rely on is DH’s ‘bench depth’ and the fact that Ed has a group of extremely bright individuals to pull from to solve problems. I am very happy to recommend Defined Health.”

Terry J. Conrad, Pharmaceutical Business Development Executive

“I have engaged Defined Health on multiple projects and always found their insights into oncology, the marketplace, emerging trends and technologies to be extremely valuable. Defined Health has a deep understanding of the science and evolving marketplace in oncology and their work has played an integral role in shaping various therapeutic and molecule strategies at Lilly.”

Lilly
Rod J. Taylor (Former)Marketing Director, Oncology New Product Planning Eli Lilly and Company

“We’ve worked with Defined Health since our start-up. They are the poster child for value-added product strategy and market analysis. They don’t just tell you what you want to know, they tell you what you don’t know but should.”

TheMedicinesCompany
Clive A. Meanwell, MD, PhD Chairman & CEO The Medicines Company

“I have been a client of Defined Health for over 6 years, both at my present company and my previous one. I have utilized DH whenever I have projects involving complex commercialization issues, including cutting edge clinical approaches requiring keen scientific understanding. They have provided me with critical insights, in a timely fashion, that have helped our decision-making process and that have ultimately helped shape the course of some of our key development programs.”

untitled
Jean-Sylvain Demelier Vice President, Global Oncology Marketing Bayer HealthCare Pharmaceuticals

Some of Our Clients

Actelion
arbutus
Aurigene
BD
BioTie
BioWa
Boehringer-Ingelheim
Cerberus
clavis_logo
Clovis-Oncology
More Clients...